Cronos Group Inc. (CRON)

21.69
0.69 3.29
NASDAQ : Health Technology
Prev Close 21.00
Open 21.00
Day Low/High 20.99 / 21.75
52 Wk Low/High 5.12 / 25.10
Volume 6.37M
Avg Volume 15.30M
Exchange NASDAQ
Shares Outstanding 178.72M
Market Cap 3.77B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz's addition should pacify a persistent critique of the company.

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Aurora Cannabis shares were indicated sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Aurora's prominent partner could be cannabis' key to breaking into consumer segments.

Aurora Is an 'Undervalued Company,' Says Jim Cramer

Aurora Is an 'Undervalued Company,' Says Jim Cramer

Jim Cramer discusses Real Money's stock of the day and why he believes that the company is undervalued.

Cannabis Is a Safe Haven If Economy Slows Down

Cannabis Is a Safe Haven If Economy Slows Down

Vice stocks tend to do better than the wider market during economic downturns, as the U.S. economy slows down, cannabis could be the perfect safe haven. Watch.

Cronos Is Too Expensive at Current Levels, BMO Report Says

Cronos Is Too Expensive at Current Levels, BMO Report Says

Cronos is currently trading at 85 times forward EBITDA, more than double the multiple of some of its peers in the cannabis space.

Altria Becomes Largest Shareholder In Cronos Group, A Leading Global Cannabinoid Company

Altria Becomes Largest Shareholder In Cronos Group, A Leading Global Cannabinoid Company

Altria Group, Inc. (Altria) (NYSE:MO) announced today the completion of its approximately USD $1.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BNED, EGLE, JILL, SRCI Downgrades: CNX, DLTR, FSP Initiations: CRON, SAIL Read on to get TheStreet Quant Ratings' detailed report:

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

Aurora Cannabis Is a Perfect Millennial Momentum Stock

Aurora Cannabis Is a Perfect Millennial Momentum Stock

Aurora Cannabis is big on social media.

Cronos Sells Stake in Whistler Medical Marijuana to Aurora Cannabis

Cronos Sells Stake in Whistler Medical Marijuana to Aurora Cannabis

Cronos to sell its 19% stake in Whistler to Aurora Cannabis.

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

Jim Cramer lists the great stocks and the obvious winners he wishes he had talked about more.

Can Cronos Group Soar Higher? Looks Like it

Can Cronos Group Soar Higher? Looks Like it

The stock price of the cannabis company has been on a roll and is poised to move even higher still.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

Jim Cramer says if you focus on what's going right, you'll sleep better and do a lot better with your money, too.

Waste Management, Weight Watchers, Centene: 'Mad Money' Lightning Round

Waste Management, Weight Watchers, Centene: 'Mad Money' Lightning Round

Jim Cramer weighs in on Waste Management, Weight Watchers, Centene, Aurinia Pharmaceuticals, Activision Blizzard, AbbVie, Cronos Group and more.

Cronos Group Rises Following Bernstein Initiation, Other Pot Stocks Fall

Cronos Group Rises Following Bernstein Initiation, Other Pot Stocks Fall

Jefferies gave five securities buy ratings in a note initiating coverage on the cannabis sector Monday.

Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys

Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys

Analyst Owen Bennett also says the market could rise to as high as $130 billion in 10 years.

Short-Selling Is Really Hard. Just Ask Citron Research

Short-Selling Is Really Hard. Just Ask Citron Research

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.

Primer For Overlooked Canadian Pot Stocks

Primer For Overlooked Canadian Pot Stocks

Searching Beyond Canopy Growth, Tilray and Cronos reveals a plethora of investment options with companies such as Valens GroWorks and others.

IPO Explosion: Cramer's 'Mad Money' Recap (Wednesday 2/13/19)

IPO Explosion: Cramer's 'Mad Money' Recap (Wednesday 2/13/19)

Jim Cramer sees ripple effects of a storm of IPOs, and is worried about the lack of money coming into the market.

Fitbit, Moderna, Tilray: 'Mad Money' Lightning Round

Fitbit, Moderna, Tilray: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Fitbit, Moderna, Tilray, Exelixis, Maxar Technology, International Paper and more.

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti Holdings, Cronos Group, Manitowoc, Crispr Therapeutics, Palo Alto Networks, Etsy and more.

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

Cramer's got the winners, the losers and the wild cards in the China trade brouhaha.

Investing Ideas for Extraction and Vape

Investing Ideas for Extraction and Vape

Valens GroWorks gains traction in rapidly growing space.

Pot Stocks Fade as Momentum Cools

Pot Stocks Fade as Momentum Cools

There are some big shifts Wednesday in names that have recently been the hottest.

TheStreet Quant Rating: D+ (Sell)